Variable influence of statins on isoprostanes in hyperlipidemia.
Wilhelm Auerswald Atherosclerosis Research Group, Vienna, Austria.
Helmut
H
Sinzinger
Anthony
A
Oguogho
D000328:Adult; D000924:Anticholesteremic Agents / Q000627:therapeutic use*; D000069059:Atorvastatin; D015237:Dinoprost / Q000031:analogs & derivatives* / Q000097:blood / Q000378:metabolism* / Q000652:urine; D005229:Fatty Acids, Monounsaturated / Q000627:therapeutic use; D005260:Female; D000077340:Fluvastatin; D006538:Heptanoic Acids / Q000627:therapeutic use; D006801:Humans; D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors / Q000627:therapeutic use*; D006949:Hyperlipidemias / Q000188:drug therapy*; D007211:Indoles / Q000627:therapeutic use; D028421:Isoprostanes / Q000097:blood / Q000378:metabolism* / Q000652:urine; D008148:Lovastatin / Q000627:therapeutic use; D008297:Male; D008875:Middle Aged; D017035:Pravastatin / Q000627:therapeutic use; D011758:Pyrroles / Q000627:therapeutic use; D019821:Simvastatin / Q000627:therapeutic use; D012907:Smoking
D000924:Anticholesteremic Agents; D005229:Fatty Acids, Monounsaturated; D006538:Heptanoic Acids; D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors; D007211:Indoles; D028421:Isoprostanes; D011758:Pyrroles; C075750:8-epi-prostaglandin F2alpha; D000077340:Fluvastatin; D008148:Lovastatin; D000069059:Atorvastatin; D019821:Simvastatin; D015237:Dinoprost; D017035:Pravastatin